Publication:
Orlistat as a fatty acid synthase inhibitor blocks cell survival mechanism via activating PTEN, which controls PI3K/AKT/MAPK axis in PC3 prostate cancer cells

Simple item page
dc.contributor.authorAras, Sahra
dc.contributor.authorÖzdemir, Beril Su
dc.contributor.authorPalavan Ünsal, Zeynep Narçın
dc.contributor.authorARISAN, ELİF DAMLA
dc.contributor.authorYERLİKAYA, PINAR OBAKAN
dc.contributor.authorRENCÜZOĞULLARI, ÖZGE
dc.contributor.authorKILBAŞ, PELİN ÖZFİLİZ
dc.contributor.authorID113920tr_TR
dc.contributor.authorID222563tr_TR
dc.contributor.authorID195744tr_TR
dc.contributor.authorID156421tr_TR
dc.contributor.authorID125860tr_TR
dc.contributor.authorID6125tr_TR
dc.date.accessioned2018-07-20T13:31:04Z
dc.date.available2018-07-20T13:31:04Z
dc.date.issued2017-08-30
dc.identifier.issn0168-1656
dc.identifier.other1873-4863
dc.identifier.urihttps://doi.org/10.1016/j.jbiotec.2017.06.654
dc.identifier.urihttps://hdl.handle.net/11413/2237
dc.identifier.wos413585400090
dc.language.isoen
dc.publisherElsevier Science Bv, Po Box 211, 1000 AE Amsterdam, Netherlands
dc.relationJournal Of Biotechnologytr_TR
dc.titleOrlistat as a fatty acid synthase inhibitor blocks cell survival mechanism via activating PTEN, which controls PI3K/AKT/MAPK axis in PC3 prostate cancer cellstr_TR
dc.typeArticle
dspace.entity.typePublication
local.indexed.atWOS
relation.isAuthorOfPublication3d33e154-a50c-46b8-ad6e-25a26bf11cf0
relation.isAuthorOfPublication387670e2-5a88-4937-b3da-1dda9aedfbdd
relation.isAuthorOfPublicationbbee5460-94f7-454c-931e-b41c42a30c2e
relation.isAuthorOfPublicationa500c512-a91e-4d19-bab8-804faf6648a8
relation.isAuthorOfPublication.latestForDiscovery3d33e154-a50c-46b8-ad6e-25a26bf11cf0

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Moleküler Biyoloji ve Genetik Bölümü / Department of Molecular Biology and Genetics
WoS İndeksli Yayınlar / WoS Indexed Publications